Načítá se...
The macrolide drug erythromycin does not protect the hERG channel from inhibition by thioridazine and terfenadine
The macrolide antibiotic erythromycin has been associated with QT interval prolongation and inhibition of the hERG‐encoded channels responsible for the rapid delayed rectifier K(+) current I((Kr)). It has been suggested that low concentrations of erythromycin may have a protective effect against hER...
Uloženo v:
| Vydáno v: | Physiol Rep |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7061092/ https://ncbi.nlm.nih.gov/pubmed/32147975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14814/phy2.14385 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|